Therapeutic Vaccines Moving Beyond Cancer and HIV

New Report by Applied Data Research Analyzes Technology and Commercial Factors for emerging therapeutic vaccines

[ClickPress, Tue Apr 17 2007] Distinct from prophylactic vaccines, therapeutic vaccines are designed to be administered to patients who have already acquired an illness that is capable of avoiding the immune response. By introducing disease-specific stimulatory components to the immune system in a highly structured way, therapeutic vaccines aim to selectively activate the immune system against the disease and improve the patient’s prognosis. For many illnesses such as hepatitis, tuberculosis and malaria that are refractory to conventional treatment regimens, vaccines that can engineer a specific and aggressive immune response present a highly attractive approach.

The science and technology of therapeutic vaccines are still evolving, with key elements such as disease-specific immunogenicity factors, antigen source, the role of co-stimulators and adjuvants, and vaccine delivery still under investigation for many target conditions. The highly individualized nature of the immune response makes patient variability a key focal point of vaccine design. While autologous vaccines have the advantage of being specific for each patient’s disease, they are expensive and labor intensive to create. The idea behind allogeneic vaccines is that they would work for every patient with the same disease.

These findings are contained in a new and comprehensive report – Therapeutic Vaccines – Beyond Cancer and HIV. The report has been carefully researched and written to provide timely and insightful analysis of key factors and developments shaping the therapeutic vaccine marketplace. Numerous charts, tables and graphs complement the text, with evaluations and assessments of current and probable future market developments, technology issues and business factors.

More information is available at www.applieddata.org .


About Applied Data

Applied Data Research is a healthcare therapeutics consulting firm focused on medical market strategies, product commercialization, venture development, and market research. We assist medical market participants in achieving their business objectives through the creation of detailed business development strategies, product commercialization programs, and comprehensive market and technology research and analysis.

Contact:

Greg Stone
Voice: 603-595-6225
Fax: 603-804-0466
www.applieddata.org

Source: Applied Data Research

Bookmark this release: Del.icio.us - Digg - Furl - Blinklist - Reddit